Medindia

X

Automated Cell Biology Workflows with Tecan and Miltenyi Biotec

Tuesday, August 17, 2010 General News J E 4
Advertisement
BERGISCH GLADBACH, Germany, and MANNEDORF, Switzerland, August 17, 2010 Tecan is working with Miltenyi Biotec, a leading provider ofcell biology solutions, to develop a range of automated solutions for cellbiology, based on the powerful MACS(R) Magnetic bead technology. This newagreement will allow customers to benefit from the advanced capabilities ofTecan's Freedom EVO(R) liquid handling platforms when performing a wide rangeof separation, cultivation and analysis processes for cells and biomolecules.

Tecan will be supporting full integration of the MultiMACS(TM) Separatorfamily of biomolecular and cellular separation devices onto the deck of theinstrument, as well as providing software solutions for straightforwardincorporation of complete Miltenyi Biotec systems, including the autoMACS(R)Pro Separator, the gentleMACS(TM) Dissociator and the MACSQuant(R) Analyzer."We are extremely pleased to be working together with Miltenyi Biotec toprovide valuable automated solutions to our customers in this fast growingarea of cell biology," commented Christoph Kaufmann, Tecan's Head of ProductManagement and Marketing.

"Miltenyi Biotec's expertise in cellular biology and the flexible rangeof high quality products will now come with the added advantages ofautomation, ensuring that our customers will benefit from an unrivalledportfolio of solutions for processing and analysis of cells andbiomolecules," added Uwe Janssen, Business Development at Miltenyi Biotec.

For more information about automated solutions based on MACS Technology,please visit http://www.miltenyibiotec.com/automation. To find out more onTecan's range of automated cell biology solutions, visithttp://www.tecan.com/cellbiology.

About Miltenyi Biotec

Miltenyi Biotec's company mission is to improve scientific understandingand medical progress by providing products and services for cellulartherapies. With approx. 1100 employees in 18 countries, Miltenyi Biotecdevelops, manufactures, and commercializes innovations for both research andclinical applications. The portfolio provides integrated solutions for allareas covering sample preparation, cell separation, cell culture, flowcytometry, and molecular analysis. Visit http://www.miltenyibiotec.com tolearn more.

About Tecan

Tecan (http://www.tecan.com) is a leading global provider of laboratoryinstruments and solutions in biopharmaceuticals, forensics, and clinicaldiagnostics. The company specializes in the development, production anddistribution of automation solutions for laboratories in the life sciencessector. With its subsidiary REMP (http://www.remp.com), Tecan is the marketleader in automated laboratory storage and logistics systems. Its clientsinclude pharmaceutical and biotechnology companies, university researchdepartments and diagnostic laboratories. Founded in Switzerland in 1980, thecompany has manufacturing, research and development sites in both NorthAmerica and Europe and maintains a sales and service network in 52 countries.In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million; EUR250.7 million). Registered shares of Tecan Group are traded on the SIX SwissExchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).For more information about Miltenyi Biotec, please contact: Miltenyi Biotec GmbH Friedrich-Ebert-Strasse 68, 51429 Bergisch Gladbach, Germany, T: +49-2204-8306-0, F: +49-2204-85197 automation@miltenyibiotec.com, http://www.miltenyibiotec.com Press contact: Prof. Dr. Uwe Heinlein, Corporate Communications T: +49-2204-8306-6590 uweh@miltenyibiotec.de For more information about Tecan, please contact: Tecan Group Ltd Seestrasse 103, CH-8708 Mannedorf T +41-44-922-81-11, F +41-44-922-81-12 info@tecan.com, http://www.tecan.com Press contact: Tanja Kaiser, Marketing Communications +41-44-922-8308 Tanja.Kaiser@tecan.com

SOURCE Miltenyi Biotec GmbH
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds Obama's Healthcare Reform Bill a...
S
Three Companies Receive C. Everett Koop National H...